Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia
- PMID: 11764081
- DOI: 10.1309/1TYF-VPM9-CQ2C-B0TF
Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia
Abstract
We compared surface immunoglobulin heavy chain isotype expression with a number of laboratory, morphologic, and immunophenotypic features in a series of 76 cases of B-cell chronic lymphocytic leukemia (B-CLL). Fifty-five cases were IgM+/IgD+, a phenotype associated with antigenically naïve B cells; 16 cases expressed IgD without IgM, a phenotype seen in a subset of normal B cells with extensive somatic immunoglobulin variable region (IgV) gene mutations; and 5 cases were IgD-, a phenotype associated with memory B cells. WBC count, atypical morphologic features, atypical immunophenotypic characteristics, and CD38 expression were nonrandomly distributed among the 3 categories of heavy chain isotype expression. Moreover, a WBC count more than 30,000/microL (30 x 10(9)/L), atypical morphologic features, and CD38 expression in more than 30% of neoplastic cells (all adverse prognostic factors in B-CLL) were less common among IgD-only cases than among IgM+/IgD+ and IgD- cases. These data demonstrate that surface immunoglobulin heavy chain isotype expression is associated with several laboratory, morphologic, and immunophenotypic features in B-CLL. The subset of B-CLL with the IgD-only phenotype is associated with several favorable prognostic factors, suggesting the possibility that IgD-only B-CLL may be associated with a favorable prognosis.
Similar articles
-
Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.Clin Cancer Res. 2006 Mar 15;12(6):1672-9. doi: 10.1158/1078-0432.CCR-05-2164. Clin Cancer Res. 2006. PMID: 16551848
-
IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.J Clin Invest. 1996 Jul 15;98(2):290-8. doi: 10.1172/JCI118792. J Clin Invest. 1996. PMID: 8755637 Free PMC article.
-
HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.J Clin Invest. 2005 Jun;115(6):1644-50. doi: 10.1172/JCI24276. J Clin Invest. 2005. PMID: 15931393 Free PMC article.
-
The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):340-6. J Biol Regul Homeost Agents. 2004. PMID: 15786702 Review.
-
The normal counterpart to the chronic lymphocytic leukemia B cell.Best Pract Res Clin Haematol. 2007 Sep;20(3):385-97. doi: 10.1016/j.beha.2007.02.005. Best Pract Res Clin Haematol. 2007. PMID: 17707828 Review.
Cited by
-
Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasia.Int J Clin Exp Pathol. 2012;5(2):110-8. Epub 2012 Feb 12. Int J Clin Exp Pathol. 2012. PMID: 22400070 Free PMC article.
-
Detection and Characterization of Paraproteinemia in Canine Chronic B-cell Lymphocytic Leukemia Using Routine and Free Light Chain Immunofixation.Vet Clin Pathol. 2022 Dec;51(4):551-559. doi: 10.1111/vcp.13156. Epub 2022 Jul 26. Vet Clin Pathol. 2022. PMID: 35883213 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials